Abstract:
Cardiovascular Diseases (CVDs) are the
leading non-communicable diseases and also leading cause of morbidity and
mortality worldwide. Low Molecular Weight Heparin (LMWHs) is frequently
prescribed medication in CVDs. Prescribing pattern of LMWHs in CVDs is
necessary to recommends modifications to achieve rational and cost-effective
medical care.